The Patent Finder

Terms ending in 2033

Biodesix, Inc.

Every in-force patent on Biodesix, Inc.'s record whose computed term ends in 2033, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 8,467,988Method and System for Validation of Mass Spectrometer Machine Performance
In force
 · High confidence
Biodesix, Inc.In forceHigh confidence
US 9,403,889Diagnostic Lung Cancer Panel and Methods for Its Use
In force
 · High confidence
Biodesix, Inc.In forceHigh confidence
US 11,467,167SRM Methods in Alzheimer's Disease and Neurological Disease Assays
In force
 · Medium confidence
Biodesix, Inc.In forceMedium confidence
US 9,279,798Deep-MALDI TOF mass spectrometry of complex biological samples, e.g., serum, and uses thereof
In force
 · High confidence
Biodesix, Inc.In forceHigh confidence
US 9,606,101Deep MALDI TOF Mass Spectrometry of Complex Biological Samples, e.g., Serum, and Uses Thereof
In force
 · High confidence
Biodesix, Inc.In forceHigh confidence
US 9,201,044Compositions, Methods and Kits for Diagnosis of Lung Cancer
In force
 · High confidence
Biodesix, Inc.In forceHigh confidence
6 of 6 patents shown. Soonest term end first, then patent number.
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited